Net Income (Loss) Attributable to Parent of EXOZYMES INC. from 31 Mar 2023 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
- Summary
-
EXOZYMES INC. quarterly and annual Net Income (Loss) Attributable to Parent in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
- EXOZYMES INC. Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2025 was $2,655,036, a 45% decline year-over-year.
- EXOZYMES INC. Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2025 was $9,158,734, a 56% decline year-over-year.
- EXOZYMES INC. annual Net Income (Loss) Attributable to Parent for 2025 was $9,158,734, a 56% decline from 2024.
- EXOZYMES INC. annual Net Income (Loss) Attributable to Parent for 2024 was $5,861,335, a 188% decline from 2023.
- Source SEC data
- View on sec.gov
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)
EXOZYMES INC. Quarterly Net Income (Loss) Attributable to Parent (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $9,158,734 | $2,655,036 | -$819,062 | -45% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 30 Mar 2026 | 2025 | FY |
| Q3 2025 | $8,339,672 | $2,286,991 | -$630,618 | -38% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $7,709,054 | $2,360,286 | -$999,756 | -73% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q1 2025 | $6,709,298 | $1,856,421 | -$847,963 | -84% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q4 2024 | $5,861,335 | $1,835,974 | -$737,410 | -67% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 30 Mar 2026 | 2025 | FY |
| Q3 2024 | $5,123,925 | $1,656,373 | -$1,135,777 | -218% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q2 2024 | $3,988,148 | $1,360,530 | -$1,182,451 | -664% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q1 2024 | $2,805,697 | $1,008,458 | -$767,308 | -318% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q4 2023 | $2,038,389 | $1,098,564 | 01 Oct 2023 | 31 Dec 2023 | 10-K | 31 Mar 2025 | 2024 | FY | ||
| Q3 2023 | $520,596 | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 12 Nov 2024 | 2024 | Q3 | |||
| Q2 2023 | $178,079 | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 12 Nov 2024 | 2024 | Q3 | |||
| Q1 2023 | $241,150 | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 12 Nov 2024 | 2024 | Q3 |
EXOZYMES INC. Annual Net Income (Loss) Attributable to Parent (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $9,158,734 | -$3,297,399 | -56% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 30 Mar 2026 | 2025 | FY |
| 2024 | $5,861,335 | -$3,822,946 | -188% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 30 Mar 2026 | 2025 | FY |
| 2023 | $2,038,389 | 01 Jan 2023 | 31 Dec 2023 | 10-K | 31 Mar 2025 | 2024 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.